April 22, 2026 - April 23, 2026
Advance Your Skills in Evaluating New Health Technologies Early in Development
This intermediate course explores how early health technology assessment (early HTA) can guide investment, development, and implementation decisions long before full clinical data are available. Participants will examine how early insights into clinical impact, adoption pathways, and implementation challenges can shape smarter product development across a variety of health technologies.
Technical Topics Include:
• Importance and limitations of early HTA in product development
• Decision and evaluation frameworks used by key stakeholders
• Methods for generating evidence when data are limited
• Approaches for assessing early clinical and implementation impact
• Case studies focused on non-pharmaceutical technologies
This Course Includes Practical Tools and Concepts That Can Be Immediately Applied, Including:
• Structured exercises on framing early product development questions
• Techniques for identifying appropriate data sources and analysis methods
• Real-world examples of stakeholder collaboration in early HTA
PREREQUISITE: This course requires familiarity with basic HTA concepts and methodologies.
LEVEL: Intermediate
TRACK: Health Technology Assessment
Faculty
Schedule:
LENGTH: 4 Hours | Course runs 2 consecutive days, 2 hours each day
ISPOR short courses are designed to enhance knowledge and techniques in core health economics and outcomes research (HEOR) topics as well as emerging trends in the field. Short courses offer 4 or 8 hours of premium scientific education and an electronic course book. Active attendee participation combined with our expert faculty creates an immersive and impactful learning experience. Short courses are not recorded and are only available during the live course presentation.